Business & regional news

Pharmacy Benefit agreements expand portfolio coverage to simplify access for eligible customers and providers

Results from Australia, Japan and Hong Kong highlight the potential impact across healthcare systems in the Asia-Pacific region

First patient successfully treated by Ajit Rao, MD, at The Mount Sinai Hospital, NY

Onyx™ 18, 34 Liquid Embolic System offers step forward in treatment options for cSDH

Now supported with effectiveness evidence, Medtronic DBS is the first and only U.S. FDA approved system to treat Dystonia symptoms

APHRS.25: Medtronic showcases breadth of defibrillation portfolio with outcomes from extravascular and transvenous defibrillation studies for the treatment of dangerous heart rhythm episodes

Confirmation comes from the position paper published by the Italian Society of Nephrology (SIN), expanding the indication of RDN to a complex and high-risk patient population

Recognition highlights Medtronic design excellence and commitment to improving patient lives

Medtronic also announced completion of enrollment in SPYRAL AFFIRM, which aims to build robust real-world evidence across traditionally underserved patient populations

Stedi Extra Support Guidewire Delivers Enhanced Support for Stability, Safety, and Predictability During Valve Deployment for Aortic Stenosis

Partnership launches AI solution to enhance predictive heart valve visualization and personalize valve treatment planning decisions enabling the future of TAVR for structural heart patients

Avalus Ultra valve expands Medtronic Cardiac Surgery’s portfolio of
cardiac surgical innovations

With this labeling approval, Medtronic continues to lead the way in advancing aortic care with clinical evidence for the treatment of ruptured abdominal aortic aneurysms (rAAA). Medtronic plc, a...

Findings highlight the potential of new investigational waveforms for the all-in-one mapping and dual-energy ablation system in advancing treatment for ventricular arrhythmia patients

Backed by exceptional clinical outcomes, the Neuroguard IEP™ System’s unique 3-in-1 design provides enhanced embolic protection when it matters most.1-5, † Medtronic, a global leader in...

New VitalFlow system expands Medtronic Cardiac Surgery’s portfolio globally

Medtronic expands its cardiac surgery portfolio with the European launch of the Penditure LAA Exclusion System

Dr. Arthur brings more than 20 years of experience as a practicing neurosurgeon and a commitment to innovation, patient safety, and improving stroke care outcomes

London office expansion underlines Medtronic’s commitment to fostering cross-industry collaboration, contributing to ambitions of the NHS 10-Year Health Plan and driving surgical innovation.

The pivotal Medtronic Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease (ADAPT-PD) trial demonstrates global clinical effectiveness, long-term safety, and patient preference

After three years, most insulin was delivered automatically by the system, and those who used the recommended optimal settings experienced the greatest benefits.

Japan is now the 77th country to receive regulatory approval for the Symplicity Spyral Renal Denervation System

The upcoming U.S. launch of the small-diameter OmniaSecure defibrillation lead will introduce the first FDA-approved lead for both adults and adolescent pediatric patients

Indication demonstrates Medtronic’s commitment to innovative patient-centered solutions shaping the future of TAVR

To address the widespread prevalence of varicose veins as a serious health condition, Medtronic has launched the #KabTakKarogeIgnore campaign in India. The initiative aims to build awareness of...

Albany Medical Center performs first patient procedure in clinical trial for use of peripheral vasculature liquid embolization for active arterial hemorrhage

Data highlights Americans’ shifting preferences toward chronic condition management

Exclusive distribution agreement with FMD Co. Ltd. expands peripheral arterial disease treatment portfolio with new suite of guidewires

The company also announces plans to share new gynecologic data
for the Hugo™ RAS system and conduct a telesurgery demo at the
Society of Robotic Surgery 2025 Annual Meeting in Strasbourg, France

Medtronic advances pipeline with update on multi-organ denervation study and additional data recently presented at EuroPCR 2025